Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy

被引:150
作者
Llovet, JM
Bruix, J
Gores, GJ
机构
[1] Univ Barcelona, Hosp Clin, Inst Invest Biomed August Pi I Sunyer, Barcelona Clin Liver Canc Grp,Liver Unit, Barcelona 08036, Catalonia, Spain
[2] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA
关键词
D O I
10.1053/he.2000.6959
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:1019 / 1021
页数:3
相关论文
共 32 条
[1]   PRIMARY-TREATMENT OF HEPATOCELLULAR-CARCINOMA BY ARTERIAL CHEMOEMBOLIZATION [J].
BISMUTH, H ;
MORINO, M ;
SHERLOCK, D ;
CASTAING, D ;
MIGLIETTA, C ;
CAUQUIL, P ;
ROCHE, A .
AMERICAN JOURNAL OF SURGERY, 1992, 163 (04) :387-394
[2]   LIVER RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA IN CIRRHOTIC-PATIENTS [J].
BISMUTH, H ;
CHICHE, L ;
ADAM, R ;
CASTAING, D ;
DIAMOND, T ;
DENNISON, A .
ANNALS OF SURGERY, 1993, 218 (02) :145-151
[3]   Liver transplantation for hepatocellular carcinoma [J].
Bismuth, H ;
Majno, PE ;
Adam, R .
SEMINARS IN LIVER DISEASE, 1999, 19 (03) :311-322
[4]  
Bruix J, 1999, HEPATOLOGY, V30, p223A
[5]   Surgical resection of hepatocellular carcinoma in cirrhotic patients: Prognostic value of preoperative portal pressure [J].
Bruix, J ;
Castells, A ;
Bosch, J ;
Feu, F ;
Fuster, J ;
GarciaPagan, JC ;
Visa, J ;
Bru, C ;
Rodes, J .
GASTROENTEROLOGY, 1996, 111 (04) :1018-1022
[6]   Preoperative hepatic artery chemoembolization followed by orthotopic liver transplantation for hepatocellular carcinoma [J].
Harnois, DM ;
Steers, J ;
Andrews, JC ;
Rubin, JC ;
Pitot, HC ;
Burgart, L ;
Wiesner, RH ;
Gores, GJ .
LIVER TRANSPLANTATION AND SURGERY, 1999, 5 (03) :192-199
[7]   HEPATIC RESECTION VERSUS TRANSPLANTATION FOR HEPATOCELLULAR-CARCINOMA [J].
IWATSUKI, S ;
STARZL, TE ;
SHEAHAN, DG ;
YOKOYAMA, I ;
DEMETRIS, AJ ;
TODO, S ;
TZAKIS, AG ;
VANTHIEL, DH ;
CARR, B ;
SELBY, R ;
MADARIAGA, J .
ANNALS OF SURGERY, 1991, 214 (03) :221-229
[8]   Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial [J].
Lau, WY ;
Leung, TWT ;
Ho, SKW ;
Chan, M ;
Machin, D ;
Lau, J ;
Chan, ATC ;
Yeo, W ;
Mok, TSK ;
Yu, SCH ;
Leung, NWY ;
Johnson, PJ .
LANCET, 1999, 353 (9155) :797-801
[9]  
LAUPACIS A, 1992, CAN MED ASSOC J, V146, P473
[10]   Natural history of untreated nonsurgical hepatocellular carcinoma:: Rationale for the design and evaluation of therapeutic trials [J].
Llovet, JM ;
Bustamante, J ;
Castells, A ;
Vilana, R ;
Ayuso, MD ;
Sala, M ;
Brú, C ;
Rodés, J ;
Bruix, J .
HEPATOLOGY, 1999, 29 (01) :62-67